• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-149 通过靶向 TREM2 和调节 β-连环蛋白通路促进胃癌对 5-FU 的耐药性。

miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway.

机构信息

Department of Gastroenterology, The First People's Hospital of Suqian, Su'qian, Jiangsu, 223800, China.

Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210006, China.

出版信息

Biochem Biophys Res Commun. 2020 Nov 12;532(3):329-335. doi: 10.1016/j.bbrc.2020.05.135. Epub 2020 Sep 22.

DOI:10.1016/j.bbrc.2020.05.135
PMID:32977944
Abstract

Drug resistance remains the unresolved obstacle for gastric cancer (GC) treatment. Recently more and more studies have shown that microRNAs are involved in cancer resistance and could apply to drug resistance therapy in tumors. The relationship between miR-149 and 5-fluorouracil (5-FU) resistance in GC remains unclear. Here we detected miR-149 expression in 5-FU resistance tumor tissues and cell lines, and found that miR-149 expression is upregulated in AGS/5-FU cells compared with AGS cells. Further experiments indicated that overexpression of miR-149 can alleviate 5-FU-induced apoptosis and proliferation inhibition by targeting TREM2. It was also confirmed that TREM2 regulated 5-FU resistance through β-catenin pathway. Generally speaking, our results indicated that miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway.

摘要

耐药性仍然是胃癌 (GC) 治疗中未解决的障碍。最近越来越多的研究表明,microRNAs 参与癌症耐药性,并可应用于肿瘤的耐药性治疗。miR-149 与 GC 中 5-氟尿嘧啶 (5-FU) 耐药性之间的关系尚不清楚。在这里,我们检测了 5-FU 耐药肿瘤组织和细胞系中的 miR-149 表达,发现与 AGS 细胞相比,AGS/5-FU 细胞中 miR-149 的表达上调。进一步的实验表明,过表达 miR-149 可以通过靶向 TREM2 减轻 5-FU 诱导的细胞凋亡和增殖抑制。还证实 TREM2 通过 β-连环蛋白途径调节 5-FU 耐药性。总的来说,我们的研究结果表明,miR-149 通过靶向 TREM2 和调节 β-连环蛋白途径促进胃癌中 5-FU 的耐药性。

相似文献

1
miR-149 contributes to resistance of 5-FU in gastric cancer via targeting TREM2 and regulating β-catenin pathway.miR-149 通过靶向 TREM2 和调节 β-连环蛋白通路促进胃癌对 5-FU 的耐药性。
Biochem Biophys Res Commun. 2020 Nov 12;532(3):329-335. doi: 10.1016/j.bbrc.2020.05.135. Epub 2020 Sep 22.
2
Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.微小RNA-204通过靶向转化生长因子β受体2介导的上皮-间质转化使胃癌细胞对5-氟尿嘧啶敏感
Cell Physiol Biochem. 2018;47(4):1533-1545. doi: 10.1159/000490871. Epub 2018 Jun 21.
3
MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.miR-195 通过靶向胃癌细胞中的 HMGA1 逆转 5-FU 耐药性。
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3771-3778. doi: 10.26355/eurrev_201905_17803.
4
MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.微小RNA-27a通过抑制肝癌细胞中的FZD7/β-连环蛋白通路来调节多药耐药蛋白1/ P-糖蛋白的表达。
Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7.
5
Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.小豆蔻明,一种天然查尔酮,通过靶向 Wnt/β-连环蛋白信号通路降低胃癌细胞对 5-氟尿嘧啶的耐药性。
Invest New Drugs. 2020 Apr;38(2):329-339. doi: 10.1007/s10637-019-00781-9. Epub 2019 May 17.
6
Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.微小RNA-193-3p的下调通过调控PTEN基因抑制人胃癌的肿瘤增殖、迁移和化疗耐药性。
Tumour Biol. 2016 Jul;37(7):8941-9. doi: 10.1007/s13277-015-4727-x. Epub 2016 Jan 11.
7
Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.敲低长链非编码 RNA HOTAIR 通过上调 miR-34a 抑制 PI3K/Akt 和 Wnt/β-catenin 信号通路抑制胃癌细胞顺铂耐药。
Int J Biol Macromol. 2018 Feb;107(Pt B):2620-2629. doi: 10.1016/j.ijbiomac.2017.10.154. Epub 2017 Oct 26.
8
Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.迷迭香酸通过下调 FOXO4 靶向 miR-6785-5p 降低胃癌细胞对 5-氟尿嘧啶的耐药性。
Biomed Pharmacother. 2019 Jan;109:2327-2334. doi: 10.1016/j.biopha.2018.10.061. Epub 2018 Nov 30.
9
Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.分泌型载脂蛋白 J(sCLU)过表达通过靶向 miR-195-5p 诱导人胃癌细胞化疗耐药。
Bioengineered. 2020 Dec;11(1):472-483. doi: 10.1080/21655979.2020.1747825.
10
Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer.壳聚糖-明胶-EGCG 纳米颗粒介导的长非编码 RNA TMEM44-AS1 沉默激活 P53 信号通路协同逆转胃癌 5-FU 耐药性。
Adv Sci (Weinh). 2022 Aug;9(22):e2105077. doi: 10.1002/advs.202105077. Epub 2022 Jun 19.

引用本文的文献

1
A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches.通过人工智能方法检测卵巢癌复发的诊断 miRNA 面板。
J Cancer Res Clin Oncol. 2023 Jan;149(1):325-341. doi: 10.1007/s00432-022-04468-2. Epub 2022 Nov 15.
2
Friend and foe: the regulation network of ascites components in ovarian cancer progression.友与敌:卵巢癌进展过程中腹水成分的调控网络
J Cell Commun Signal. 2023 Sep;17(3):391-407. doi: 10.1007/s12079-022-00698-8. Epub 2022 Oct 13.
3
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.
癌症耐药性中的非编码RNA:潜在机制与临床应用
Front Oncol. 2022 Aug 17;12:951864. doi: 10.3389/fonc.2022.951864. eCollection 2022.
4
The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer.非编码RNA在胃癌中的分子作用及临床意义
Front Cell Dev Biol. 2021 Dec 13;9:802745. doi: 10.3389/fcell.2021.802745. eCollection 2021.
5
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer.微小RNA在胃癌耐药中的作用机制及临床意义
Front Oncol. 2021 Nov 29;11:768918. doi: 10.3389/fonc.2021.768918. eCollection 2021.
6
CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1.环状 ARVCF 通过改变 miR-1205 和 FGFR1 促进胃癌顺铂耐药。
Front Genet. 2021 Nov 25;12:767590. doi: 10.3389/fgene.2021.767590. eCollection 2021.
7
TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy.TREM2:在癌症免疫治疗中与免疫检查点抑制剂并驾齐驱。
Front Immunol. 2021 Sep 3;12:716710. doi: 10.3389/fimmu.2021.716710. eCollection 2021.
8
Understanding the regulation of β-catenin expression and activity in colorectal cancer carcinogenesis: beyond destruction complex.了解β-连环蛋白表达和活性在结直肠癌发生过程中的调控:超越破坏复合体。
Clin Transl Oncol. 2021 Dec;23(12):2448-2459. doi: 10.1007/s12094-021-02686-7. Epub 2021 Aug 23.
9
5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent.5-氟尿嘧啶:关于调节机制在导致对这种化疗药物产生耐药性中所起作用的叙述性综述
Front Oncol. 2021 Apr 19;11:658636. doi: 10.3389/fonc.2021.658636. eCollection 2021.
10
MiR-450a-5p Inhibits Gastric Cancer Cell Proliferation, Migration, and Invasion and Promotes Apoptosis Targeting CREB1 and Inhibiting AKT/GSK-3β Signaling Pathway.MiR-450a-5p通过靶向CREB1并抑制AKT/GSK-3β信号通路来抑制胃癌细胞的增殖、迁移和侵袭并促进凋亡。
Front Oncol. 2021 Mar 29;11:633366. doi: 10.3389/fonc.2021.633366. eCollection 2021.